Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Nizhnekamskneftekhim modernizes mechanical plant

12/6/23 NKNC

Phosagro offers farmers a comprehensive solution

12/6/23 PHOR

Sberbank expects fee and commission income to grow by 10%

12/6/23 SBER

Moscow Exchange placed one more issue of DFA

12/6/23 MOEX

Sberbank will create a highly qualified financial assistant

12/6/23 SBER

Sberbank outlines key goals of its development strategy until 2026

12/6/23 SBER

Rostelecom will build cell towers along federal highways

12/6/23 RTKM

Sber admits individuals to the digital financial assets platform

12/6/23 SBER

Kamaz to increase production volume by 7%

12/6/23 KMAZ

Magnit opened the first mini-markets Magnit near

12/6/23 MGNT